GleamWall
中文EN

TDOC Teladoc Health, Inc.

Services-Offices & Clinics of Doctors of Medicine · NYSE · SEC CIK 1477449 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-2.4%
TTM net income YoY30.8%
TTM EPS YoY31.7%
Revenue 3-yr CAGR-1.5%
Net income 3-yr CAGR—

Margins

Gross margin68.6%
Operating margin-6.6%
Net margin-6.3%
FCF margin10.6%
EBITDA margin—

Returns

ROE-11.5%
ROA-5.5%
ROIC (approx.)-23.2%
Asset turnover0.87x

Leverage & solvency

Liabilities / assets53.3%
Debt / equity0.00x
Current ratio0.87x
Interest coverage-8.00x

Cash quality & payout

Operating cash flow / net income-1.73x
Accruals ratio-15.0%
Payout ratio—
Capex / revenue0.3%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$2.53B$2.57B$2.60B$2.41B$2.03B
Cost of revenue$771.59M$751.27M$760.03M$743.99M$650.26M
Gross profit$1.76B$1.82B$1.84B$1.66B$1.38B
R&D expense$277.92M$307.27M$348.52M$333.63M$311.88M
SG&A expense$431.89M$435.49M$464.66M$449.86M$438.01M
Operating income-$262.95M-$1.02B-$248.55M-$13.65B-$265.63M
Interest expense$19.71M$23.80M$22.28M$21.94M$81.14M
Pretax income-$235.53M-$993.65M-$219.61M-$13.66B-$384.66M
Income tax-$35.21M$7.59M$760,000-$3.81M$44.14M
Net income-$200.32M-$1.00B-$220.37M-$13.66B-$428.79M
EBITDA———-$13.40B-$61.39M
EPS (basic)-1.14-5.87-1.34-84.60-2.73
EPS (diluted)-1.14-5.87-1.34-84.60-2.73
Weighted avg. shares (diluted)176.22M170.56M164.58M161.46M156.94M
Banking
Net interest income———-$9.27M-$80.36M
Balance sheet
Cash & equivalents$781.08M$1.30B$1.12B$918.18M$893.48M
Short-term investments———$0$2.54M
Receivables$192.83M$214.15M$217.42M$210.55M$168.96M
Inventory$38.20M$38.14M$29.51M$56.34M$73.08M
Current assets$1.12B$1.66B$1.49B$1.32B$1.23B
PP&E, net$26.97M$29.49M$32.03M$29.64M$27.23M
Goodwill$283.19M$283.19M$1.07B$1.07B$14.50B
Intangibles$1.30B$1.43B$1.68B$1.84B$1.91B
Total assets$2.86B$3.52B$4.39B$4.35B$17.73B
Current liabilities$404.74M$941.53M$420.62M$399.77M$331.01M
Short-term debt————$0
Total liabilities$1.47B$2.03B$2.07B$2.04B$1.69B
Shareholders' equity$1.39B$1.49B$2.33B$2.31B$16.05B
Shares outstanding178.32M173.41M166.66M162.84M160.47M
Cash flow statement
Operating cash flow$294.36M$293.68M$350.02M$189.29M$193.99M
Capital expenditure$8.89M$10.79M$11.46M$16.48M$8.53M
Free cash flow$285.46M$282.89M$338.56M$172.81M$185.46M
Investing cash flow-$266.00M-$124.05M-$156.35M-$167.74M-$72.98M
Financing cash flow-$551.65M$8.31M$10.85M$6.50M$40.95M
Depreciation & amortization———$256.03M$204.24M
Stock-based compensation$80.41M$145.95M$201.55M$217.85M$302.59M

Free plan shows the latest 5 periods; Pro shows all 13 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.